title: Pulmonary hypertension in patients with hemoglobinopathies: could a mechanism for dysfunction provide an avenue for novel therapeutics?
authors.forename: Elaina E
authors.initials: EE
authors.lastname: Lin
authors.forename: Mark T
authors.initials: MT
authors.lastname: Gladwin
authors.forename: Roberto F
authors.initials: RF
authors.lastname: Machado
mesh_terms: D000328:Adult; D006453:Hemoglobinopathies / Q000150:complications*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D010879:Piperazines / Q000627:therapeutic use*; D011379:Prognosis; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate